<DOC>
	<DOCNO>NCT02060149</DOCNO>
	<brief_summary>The mortality pneumonia extensively drug resistant Acinetobacter baumannii ( XDRAB ) still high , even patient receive certain strong anti-infection treatment u combination cefoperazone-sulbactam ( C/S ) minocycline . Health airway line fluid mildly alkaline airway acidification usually appear infection XDRAB . The hypothesis offer biologic activity XDRAB might inhibit circumstance include pH change . In vitro study observe inhibit effect antibiotic XDRAB growth improve significantly alkaline solution within scope physiology . So aim clinical study explore effect nebulization alkaline Solution C/S plus minocycline pneumonia XDRAB .</brief_summary>
	<brief_title>The Effect Nebulization Alkaline Solution Treating XDRAB Pneumonia With C/S Plus Minocycline</brief_title>
	<detailed_description>Pneumonia patient XDRAB eligible multicenter study , meet exclusion criterion sign inform consent . They receive anti-infection protocol Cefoperazone/ sulbactam 3.0g（intravenous infusion , q8h q6h ) combine minocycline doxycycline 100mg ( oral , q12h ) . All enrol patient randomly divide three group accord difference pH value aerosol inhalation sodium bicarbonate solution . Group one blank-control patient receive usual antibiotic treatment without inhalation . The pH value group two 7.4 group 7.8 . Each time volume aerosol solution 5ml , q8h . The average course treatment two week . Clinical index collect include vital sign , pulmonary rale , cough level , expectoration level , sputum color , blood count , arterial blood gas , biochemical parameter , chest X-ray score , APACHE II score , clinical pulmonary infection score , ECG , sputum culture , et al.The primary endpoint pathogenic clearance rate recovery rate . The secondary end point adverse reaction rate .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Cefoperazone</mesh_term>
	<mesh_term>Sulperazone</mesh_term>
	<criteria>Age : 18 75 year old , male female The pneumonia patient meet diagnostic criterion , clinical pulmonary infection score ( CPIS ) ≥ 5 ; The sputum bacteriology detection prompt Acinetobacter baumannii culture pathogens concentration meet diagnostic criterion Chinese hospitalacquired pneumonia diagnosis treatment guideline , 2002 edition `` Acinetobacter baumannii susceptibility result show 1 2 sensitive antimicrobial drug ( polymyxin , minocycline tegafur doxycycline ) ; Cephalosporins tetracyclines drug treatment without history allergy contraindication ; Be able accept inhalation therapy . Informed consent gain Refused accept inhalation therapy Renal insufficiency , creatinine clearance ( CockcroftGault formula ) ( CLcr ) 15 ml / min less ; Liver dysfunction , define ChildPugh score B C Within one week start cefoperazone sulbactam , minocycline treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Extensively Drug Resistant A. Baumannii</keyword>
</DOC>